Navigation Links
Software Techniques Inc. Selects M2SYS Fingerprint Software to Meet Continuous Growth and Demand for Desktop Biometric Time & Attendance Solutions
Date:11/27/2007

Innovative Fingerprint Software Enhances Biometric Time Clock Security and

Improves Payroll Productivity Without Fingerprint SDK Development

ATLANTA, Nov. 27 /PRNewswire/ -- M2SYS Technology, an award-winning biometric fingerprint technology firm, announced today that Software Techniques Inc. has enhanced their TimeKRON PC-based time and attendance software by integrating M2SYS' Bio-SnapON(TM) solution.

Bio-SnapON(TM) allows companies to add biometric functionality to their software almost instantly, without affecting existing source code. This enabled Software Techniques to seamlessly interface biometric fingerprint technology with their TimeKRON solution with no additional development; immediately strengthening customer value.

The addition of another leading time and attendance software provider to M2SYS' list of strategic partners shows the growing demand for PC-based biometric time and attendance software. Instead of costly biometric wall mounted time clocks or old fashioned manual time sheets, companies such as Software Techniques can offer their customers the convenience and complete control of utilizing Bio-SnapON(TM), which eliminates buddy punching and improves profitability.

"Many companies don't have the budget for expensive wall-mounted biometric time-clock units," explained Michael Trader, President of M2SYS. "With Bio-SnapON(TM), time and attendance software providers like Software Techniques can immediately offer an affordable, PC-based biometric time-clock solution without the hassle of fingerprint SDK integration."

"Due to M2SYS' reputation for innovative biometric technology and the simplicity of Bio-SnapON(TM), we saw it as a no-brainer," states Cynthia Chaney, Channel Sales Manager of Software Techniques. "After testing Bio-SnapON(TM), we were amazed by the speed with which we were able to add biometric features to our application."

About M2SYS Technology

Recipient of Frost & Sullivan's
'/>"/>

SOURCE M2SYS Technology
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology news :

1. Radiant Systems Selects BIO-key(R) Biometric Software for POS Solution
2. IdentiPHI Re Launches SAFmodule Software to Secure Novell(R) Networks
3. IdentiPHI Re Launches SAFmodule Software to Secure Novell(R) Networks
4. Radiant Systems Selects BIO-key(R) Biometric Software for POS Solution
5. Aware, Inc. Introduces Biometrics Software for Tenprint Autocapture
6. CIC Again Named to Software Magazines Annual Prestigious Software 500 List
7. Titanium Group Signs Letter of Intent to Acquire Multimilion Dollar Medical Software Company and Its Existing Sales Network
8. Titanium Group Signs Letter of Intent to Acquire Multimilion Dollar Medical Software Company and Its Existing Sales Network
9. NIH selects LIAI for major study on allergy molecular causes and possible treatments
10. M2SYS Partners With Gnosis Medical Services to Provide Accurate Patient Identification in Developing Countries Through Innovative Biometrics Solution
11. M2SYS Partners with SecuGen Corporation to Support Market Leading Hamster Plus Fingerprint Reader with Auto-On Technology

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...ing Harbor, N.Y. Oncologists have had their hands...have mutations that disable a protein called p53. ...s several cancer-fighting operations within cells.... often cannot be treated. , These tumors might ...ew study from Cold Spring Harbor Laboratory (CSHL)...
(Date:11/9/2009)...versity evolutionary biologists David Queller and ...peration and low conflict between components, from..."organismality," whether that thing is an animal, ...traits scientists use to describe an organism, suc...species, may not be necessary to achieve organisma...
(Date:11/9/2009)...f academic, government and industry researchers ha...esculenta) genome. The project is an important fir...is subsistence crop and addressing some of the man... world. , Cassava is a root crop that serves as ...people each day. Although it has many properties t...
Breaking Biology News(10 mins):CSHL study shows that some malignant tumors can be shut down after all 2CSHL study shows that some malignant tumors can be shut down after all 3What is the meaning of 'one'? 2What is the meaning of 'one'? 3Researchers complete draft genome sequence for cassava 2Researchers complete draft genome sequence for cassava 3Researchers complete draft genome sequence for cassava 4Injection May Heal Damaged Heart 52560 1Injection May Heal Damaged Heart 52560 2National Science Foundation Announces 2420M Research Award to South Carolina 52556 1National Science Foundation Announces 2420M Research Award to South Carolina 52556 2National Science Foundation Announces 2420M Research Award to South Carolina 52556 3More than 1 000 Underinsured and Uninsured Individuals Receive Free Dental Care 52553 1More than 1 000 Underinsured and Uninsured Individuals Receive Free Dental Care 52553 2
...) In an epidemiological study, Tufts University re...in a sample of the United States population based...LP) levels in the bloodstream. Plasma PLP is the i... current Recommended Dietary Allowance (RDA) of vi...function and important for maintaining a healthy i...
...reproduce, like all vertebrates, they either lay t... according to new research by a team of Boston Uni...ropsophus ebraccatus) in Panama that reproduces bo...ecision to lay egg masses aquatically in a pond or...ond, where the newly-hatched tadpoles simply fall ...
...quality at beaches along the Great Lakes have prom... safe for recreation. A new collaborative project ...rs when they are faced with deciding whether to cl...rative effort will draw on the expertise of U.S. G...l agencies. , The project has been funded throug...
Other Biology News:Study identifies trends of vitamin B6 status in US population sample 2Study identifies trends of vitamin B6 status in US population sample 3Reproductive plasticity revealed: Neotropical treefrog can choose to lay eggs in water or on land 2To swim or not to swim? 2
(Date:11/6/2009)...PRNewswire-FirstCall/ -- Helix BioPharma Corp. (TS...d that John Docherty, president and chief operatin...6th annual Investor Summit on November 10, 2009 at...r. Docherty will provide an overview of the Compan...nd Topical Interferon Alpha-2b. The slide show po...
(Date:11/6/2009)... ,, 3Q09 Corporate...a(TM) E.U. Marketing Authorization to Astellas Pha...mercial readiness activities Expanded management ...ng; and Director, Commercial Operations Appointed...t Committee chairman , Upcoming 2009 Milest...
(Date:11/6/2009)...PRNewswire/ -- Intarcia Therapeutics, Inc. deliver...#174; continuous delivery of exenatide) program fo...nual Diabetes Technology Meeting in San Francisco,...prnh/20050301/SFTU126LOGO ) ,, Continuous Sub...s Plasma Glucose, HbA1c and Reduces Weight in a 28...
(Date:11/5/2009)... GenVec, Inc. (Nasdaq: ...he third quarter ended September 30, 2009. GenVec ...re) for the three months ended September 30, 2009 ...share) in the comparable quarter of 2008. For the ... loss was $14.1 million ($0.15 per share), compare...
Breaking Biology Technology:Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 3NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6
...ns, and great differences among countries. This i...to use previously collected samples from biobanks ...xtremely complicated to carry out major internatio...hnology, Swedish ethics researchers at the Center ... researchers, put forward a pioneering solution: a...
...w kind of biosensor can tell., A new and deceptiv...s at Vanderbilt University that can measure the in...ical molecules including proteins, sugars, antibod...capability needed to capitalize on the new avenues...ar-plus effort to sequence the human genome. DNA i...
...ound that the body,s innate ability to adapt to re...effective and less costly artificial respirators. ...nduced sedation or paralysis currently necessary f...associative learning, or our innate ability to ada...e described in the September 12 issue of PLoS ONE,...
Other Biology Technology:Long-awaited international ethical guidelines for biobank researchers 2When proteins, antibodies and other biological molecules kiss, a new kind of biosensor can tell 2When proteins, antibodies and other biological molecules kiss, a new kind of biosensor can tell 3MIT: Leveraging learning for artificial respiration 2
ProtoArray Kinase Substrate Identification Application Kit from Invitrogen
Yeast Extract Solution from Invitrogen
GIBCO Dulbeccos Modified Eagle Medium (D-MEM) (1X); powder (low glucose) from Invitrogen
Rabbit Anti-CUGBP2 Monoclonal Antibody, Unconjugated, Clone PADZMD.495 from Invitrogen
Biology Products: